Skip to main content
Clinical Trials/NCT01919931
NCT01919931CompletedNot Applicable

Immunological and Molecular Interaction Between the Host and Candida Albicans Biofilm

Universitaire Ziekenhuizen KU Leuven1 site in 1 country237 target enrollmentStarted: March 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
237
Locations
1
Primary Endpoint
Immunological phenotyping of patients

Study Overview

Brief Summary

Candida albicans is one of the most common nosocomial infection and the onset relies on the host immune status. The purpose of this study is to determine the immunological profile of patients infected with Candida albicans, that could ideally lead to a strategy to identify patients who could benefit from prophylaxis.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients infected with Candida albicans
  • Patients not infected with Candida albicans

Exclusion Criteria

  • Underage patients
  • Non consenting patients
  • Unconscious patients

Outcomes

Primary Outcomes

Immunological phenotyping of patients

Time Frame: 2 months

Secondary Outcomes

  • Mannose Binding Lectin levels(1 month)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Immunological Interaction Between the Host... | Clinical Trial